Search
Ponatinib is used to treat chronic myelogenous leukemia in adults. Ponatinib is a novel potent, orally available small molecule multitargeted kinase inhibitor. Ponatinib inhibits both native and mutant BCR-ABL. Ponatinib is used in the treatment of chronic myeloid leukemia (CML) with BCR-ABL kinase inhibitors.
Items | Specifications | Results |
Appearance | White powder | Conforms |
Assay | ≥99.0% | 99.31% |
Product parameters | |
Cas number: | 943319-70-8 |
Appearance: | White powder |
Purity: | 99%min |
Package details: | 10g/bottle; 100g/foil bag |
Brand: | Fortunachem |
Used as antineoplastic agents.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: